Javier Rodriguez, See Remarks at BioXcel Therapeutics, Inc. (BTAI), sold 6,560 shares at $1.08 ($7K) on 2026-05-20, disclosed to the SEC on 2026-05-22.
Scheduled sale ($7k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DVA | SELL | 2024-09-17 | $19.7M | — | Filing → |
| BTAI | SELL | 2024-09-17 | $238 | — | Filing → |
| DVA | SELL | 2024-08-28 | $12.5M | — | Filing → |